HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts.

AbstractAIMS:
To evaluate whether heart failure in type 1 diabetes is linked to poor glycaemic control, coronary atherosclerosis or advanced glycation endproducts (AGEs).
METHODS:
Twenty six patients with type 1 diabetes (mean duration 32+/-5 years), and 16 age matched controls were recruited. Mean HbA(1c) through 18 years (HbA(1c)18), serum levels of AGEs and coronary atherosclerotic burden (CAB) were determined by IVUS. Peak tissue velocities and strain by tissue Doppler imaging were measured in 12 LV regions as an evaluation of LV function.
RESULTS:
Systolic tissue velocity was inversely correlated to CAB (r=0.53, p<0.01), to HbA(1c)18 (r=0.46, p<0.05) and to the duration of diabetes (r=0.46, p<0.05). Systolic strain was inversely correlated to HbA(1c)18 (r=0.45, p<0.05), to duration of diabetes (r=0.41, p<0.05), and tended to correlate with AGEs (r=0.37, p=0.07). In multiple regression analyses, CAB and HbA(1c)18 were significant independent predictors for systolic velocity, while AGEs and duration of diabetes were significant predictors of systolic strain.
CONCLUSION:
LV systolic function was impaired by increasing coronary atherosclerosis and worsening of glycaemic control. AGEs might be another mechanism for the increased risk of heart failure in type 1 diabetes.
AuthorsKjetil Steine, Jakob R Larsen, Marie Stugaard, Tore Julsrud Berg, Magne Brekke, Knut Dahl-Jørgensen
JournalEuropean journal of heart failure (Eur J Heart Fail) Vol. 9 Issue 10 Pg. 1044-50 (Oct 2007) ISSN: 1388-9842 [Print] England
PMID17719271 (Publication Type: Journal Article)
Chemical References
  • Glycated Hemoglobin A
  • Glycation End Products, Advanced
Topics
  • Adult
  • Case-Control Studies
  • Coronary Artery Disease (diagnostic imaging, physiopathology)
  • Diabetes Mellitus, Type 1 (diagnostic imaging, physiopathology)
  • Disease Progression
  • Female
  • Glycated Hemoglobin
  • Glycation End Products, Advanced
  • Heart Failure (physiopathology)
  • Heart Ventricles (diagnostic imaging, pathology)
  • Humans
  • Hyperglycemia (prevention & control)
  • Male
  • Middle Aged
  • Risk Factors
  • Time Factors
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: